|  | Cancer | Skin Cancer

Melanoma Origins: From Melanocytes to Malignancy

Melanoma arises from melanocytes—the pigment-producing cells responsible for skin color. Understanding their biology clarifies melanoma development.

Melanocyte Biology

  • Location: Primarily in the basal layer of the epidermis (every 5-10 keratinocytes); also in hair follicles, eyes, meninges, inner ear, mucosa.
  • Origin: Neural crest-derived; migrate during embryogenesis.
  • Function: Synthesize melanin (eumelanin = brown/black; pheomelanin = red/yellow) in melanosomes, transferred to keratinocytes for UV protection.
  • Regulation: MC1R receptor activation by α-MSH (UV-induced) stimulates eumelanin production.

Melanoma Pathogenesis

Genetic Drivers

  • BRAF V600E mutation: ~50% cutaneous melanomas; activates MAPK pathway.
  • NRAS mutations: ~15-20%; mutually exclusive with BRAF.
  • NF1 loss: ~10-15%; RAS pathway dysregulation.
  • TERT promoter mutations: >70%; immortalization via telomerase.
  • CDKN2A (p16) loss: Familial melanoma; cell cycle dysregulation.
  • PTEN loss, TP53 mutations: Later progression events.

UV Radiation Role

UVB causes direct DNA damage (C→T transitions); UVA generates oxidative stress. Both create "UV signature" mutations. Intermittent intense exposure (sunburns) strongly correlates with trunk/leg melanomas; chronic exposure with face/neck/scalp.

Melanoma Subtypes by Origin Site

SubtypePrimary SiteKey Features
Superficial spreadingTrunk (M), legs (F)Radial growth phase; BRAF mutant
NodularAnywhereVertical growth from onset; aggressive
Lentigo malignaSun-damaged face/neckSlow radial growth; elderly; UV signature
Acral lentiginousPalms, soles, nail bedsNon-UV; KIT mutations; all skin types
MucosalGenital, oral, sinusNon-UV; KIT, SF3B1 mutations
UvealEye (choroid, ciliary body, iris)GNAQ/GNA11 mutations; distinct biology

Precursor Lesions

  • Congenital melanocytic nevi: Large/giant (>20 cm) → 5-10% lifetime melanoma risk.
  • Atypical/dysplastic nevi: Marker of increased risk; not obligate precursors.
  • Melanoma in situ: Confined to epidermis; 100% curable with excision.

Melanoma is a malignancy of transformed melanocytes. Early detection (ABCDE: Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolution) and excision offer cure.

Skin Cancer - Related Articles